| APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
| BDNF |
P23560
|
brain derived neurotrophic factor
|
Signaling
|
0.66 |
0.345 |
0.923 |
| CA2 |
P00918
|
carbonic anhydrase 2
|
|
1.7E-06 |
0.506 |
0.808 |
| CHL1 |
O00533
|
cell adhesion molecule L1 like
|
|
8.9E-12 |
0.603 |
0.654 |
| DLG4 |
P78352
|
discs large MAGUK scaffold protein 4
|
Receptor
|
1.00 |
0.595 |
0.654 |
| DYRK1A |
Q13627
|
dual specificity tyrosine phosphorylation regulated kinase 1A
|
Kinase
|
1.00 |
0.533 |
0.769 |
| FMR1 |
Q06787
|
FMRP translational regulator 1
|
Nucleic acid binding
|
0.65 |
0.473 |
0.769 |
| FMR1-IT1 |
|
FMR1 intronic transcript 1
|
|
|
0.716 |
0.385 |
| FRAXA |
|
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation)
|
|
|
0.641 |
0.462 |
| FRAXE |
|
fragile site, folic acid type, rare, fra(X)(q28) E
|
|
|
0.636 |
0.462 |
| GABARAP |
O95166
|
GABA type A receptor-associated protein
|
Cellular structure
|
0.26 |
0.695 |
0.500 |
| GBA2 |
Q9HCG7
|
glucosylceramidase beta 2
|
|
2.0E-20 |
0.636 |
0.654 |
| GPS2 |
Q13227
|
G protein pathway suppressor 2
|
Enzyme modulator
|
5.3E-02 |
0.691 |
0.346 |
| HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
| NSD1 |
Q96L73
|
nuclear receptor binding SET domain protein 1
|
Epigenetic regulator
|
1.00 |
0.505 |
0.769 |
| SPG11 |
Q96JI7
|
SPG11 vesicle trafficking associated, spatacsin
|
|
1.6E-39 |
0.576 |
0.538 |
| VCX |
Q9H320
|
variable charge X-linked
|
|
0.34 |
0.716 |
0.538 |